Mostrando 2 resultados de: 2
Pharmacogenomic information in drug labels: European Medicines Agency perspective
ReviewAbstract: Pharmacogenomics (PGx) has a growing impact on healthcare and constitutes one of the major pillars oPalabras claves:Autores:Adrián LLerena, Caneva L., Ehmann F., Ingelman-Sundberg M., Maliepaard M., Papaluca-Amati M., Paulmichl M., Prasad K.Fuentes:scopusThe Sixth European Society of Pharmacogenomics and Personalised Therapy Congress
Conference ObjectAbstract: On 8-9 November 2022, the European Society of Pharmacogenomics and Personalised Therapy organized itPalabras claves:Autores:Adrián LLerena, Akin D., Ansari M., Bozina N., Christrup L., Daly A.K., Florindi F., Henricks L.M., Ingelman-Sundberg M., Manolopoulos V.G., Molden E., Morris T., Muller D.J., Niemi M., Patrinos G.P., Pavlovic S., Primorac D., Russmann S., Sipeky C., Stanković S., Swen J.J., Van Den Broek W., Van Schaik R.H.N., Zukic B.Fuentes:scopus